NEWS

Text-mining tools help scientists find neurology therapies

Elan Pharmaceuticals has licensed the Pathway Studio software from Ariadne. Elan is biotechnology company that develops therapies for neurology and autoimmune diseases. It chose Pathway Studio for its advanced text-mining tools, powerful experimental data interpretation and pathway analysis capability.

Ariadne’s Pathway Studio includes the ResNet database of functional relationships that can be used for assembly of biological pathways, exploring signalling networks, and to interpret microarray experimental data. MedScan’s natural language processing technology enables customers to extend ResNet though extraction of pathway-related information from biomedical literature.

Jim Miller, principal scientist at Elan Pharmaceuticals: ‘The MedScan module, in particular, gives a scientist the capability to quickly create pathways from the newest literature sources in a matter of minutes.’

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers